Journal: Translational Psychiatry
Article Title: Decoding the inflammatory signature of the major depressive episode: insights from peripheral immunophenotyping in active and remitted condition, a case–control study
doi: 10.1038/s41398-024-02902-2
Figure Lengend Snippet: A , B Cytokines, chemokines, and neurotrophic factors, were assessed employing a customized LEGENDPlex system for a human inflammatory panel 1 ( A ), and a neuroinflammation panel ( B ) determined by flow cytometry. Each panel allow the simultaneous quantification of all assessed molecules in 50 µL of the sample. The concentrations of each cytokine are determined by a standard curve provided by the kit, see Supplemental Figs. and . C IL-6 was determined by high-sensitivity (HS) ELISA kit. Independent data for each molecule is graphed and the median of each group is shown. Human Inflammatory Panel 1 includes: IL-1β, IFNγ, IL-17A, IL-33, CXCL8, IL-10, IL-12p70 and IL-23, and the Human Neuroinflammation Panel includes: β-NGF, CX3CL1, BDNF, sTREM2, IL-18, TNFα and CCL2. Major Depression Episode (MDE), active vs remitted MDE, Healthy Control (HC). Statistical differences among groups was calculated by Kruskal–Wallis rank sum test with Bonferroni adjustment for multiple comparisons . ** P -value < 0.01; * P -value < 0.05.
Article Snippet: Considering that the IL-6 measurement was under the low range of detection of the legendPlex system, we have measured this cytokine in the plasma of HC and patients with MDE employing a highly sensitive ELISA kit (Enzo Life Sciences, Supplementary Table ).
Techniques: Flow Cytometry, Enzyme-linked Immunosorbent Assay